231 related articles for article (PubMed ID: 9617836)
21. Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis.
Rarok AA; Huitema MG; van der Leij MJ; van der Geld YM; Berthold H; Schmitt J; Stegeman CA; Limburg PC; Kallenberg CG
Am J Clin Pathol; 2003 Oct; 120(4):586-95. PubMed ID: 14560570
[TBL] [Abstract][Full Text] [Related]
22. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.
Selga D; Segelmark M; Wieslander J; Gunnarsson L; Hellmark T
Clin Exp Immunol; 2004 Jan; 135(1):164-72. PubMed ID: 14678279
[TBL] [Abstract][Full Text] [Related]
23. Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA.
Capizzi SA; Viss MA; Hummel AM; Fass DN; Specks U
Kidney Int; 2003 Feb; 63(2):756-60. PubMed ID: 12631144
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
Selak S; Woodman RC; Fritzler MJ
Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
[TBL] [Abstract][Full Text] [Related]
25. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.
O'Donnell JL; Hayman MW; Spellerberg MB; McLellan AD; Brooksbank K; Chapman PT; Stamp LK
Pathology; 2007 Apr; 39(2):258-63. PubMed ID: 17454758
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
27. Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice.
Noel N; André C; Bengoufa D; Dehoulle C; Mahler M; Limal N; Godeau B; Hüe S
Autoimmun Rev; 2013 Oct; 12(12):1118-22. PubMed ID: 23800447
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
[TBL] [Abstract][Full Text] [Related]
30. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
31. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
32. Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane.
De Bandt M; Meyer O; Dacosta L; Elbim C; Pasquier C
Clin Exp Immunol; 1999 Feb; 115(2):362-8. PubMed ID: 9933466
[TBL] [Abstract][Full Text] [Related]
33. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
34. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.
Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears A; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S45-52. PubMed ID: 19646346
[TBL] [Abstract][Full Text] [Related]
35. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
36. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients.
Arranz O; Ara J; Rodriguez R; Quintó L; Font J; Mirapeix E; Darnell A
Clin Nephrol; 2001 Oct; 56(4):295-301. PubMed ID: 11680659
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis.
Feng Z; Liu P; Li Z; Sui B
J Clin Lab Anal; 2008; 22(1):73-6. PubMed ID: 18200577
[TBL] [Abstract][Full Text] [Related]
38. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
[TBL] [Abstract][Full Text] [Related]
39. Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis.
Gisslén K; Wieslander J; Westberg G; Herlitz H
J Intern Med; 2002 Feb; 251(2):129-35. PubMed ID: 11905588
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
